A single paragraph buried in Pennsylvania’s medical marijuana law will start bringing some transparency to consumer-level prices. It could also have a profound influence on medical cannabis products nationwide.
Join NORML with at least a $35 annual donation or sign up to be a sustaining $10 monthly donation before July 1 and we’ll send you this exclusive NORML drink koozie. Chances are, marijuana is safer than what’s in that can!
NORML New Jersey stormed the halls of the state legislature during Monday’s press conference, rally, and lobby day to help break the legalization deadlock and demand that state lawmakers take action in support of adult use cannabis legalization in the Garden State.
Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs.
Democratic Gov. Kate Brown has signed legislation, Senate Bill 970, prohibiting landlords from taking discriminatory action against those who either use medical cannabis or possess cannabis-related convictions. The new law takes effect on January 1, 2020.
For the first time, the House Subcommittee on Financial Services and General Government Appropriations has included language seeking to protect the employment of federal employees who consume cannabis in legal jurisdictions.
Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse. Nearly half of all respondents said that they use medical cannabis in place of other prescription medications.
Marijuana smokers and medical cannabis patients in New Jersey are to remain second class citizens. The two-ring, bipartisan political circus in Trenton has failed to deliver a promise of our freedom… again.
Welcome to the latest edition of NORML’s Weekly Legislative Roundup!
Seventy-three percent of surveyed medical specialists providing health care think cannabis benefits their patients, but only forty-six percent felt comfortable recommending it. Topping the list of complaints is the usual drug war collateral harm involving uncertainties in marijuana strains versus specific medical effects, product availabilities, and punitive state or federal regulations:
“I think in some […]